Exclusive agreement includes over $70 million in upfront and milestone payments to LENZ in addition to double-digit royalties ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, Ekterly, for a type of ...

Costco has issued recalls on several products in 2025 due to safety concerns. Shoppers should check their purchases for ...

Regeneron Pharmaceuticals’ Lynozyfic (linvoseltamab-gcpt) has been granted accelerated approval by the US Food and Drug ...

Orchard Therapeutics, a Kyowa Kirin company, today announced the last patient has been treated in a registrational trial ...

KalVista Pharmaceuticals shares jumped in premarket trading Monday after the company said it has received regulatory approval for its treatment of hereditary angioedema. Shares traded 20% higher ahead ...

Creatine and pre-workout supplements may boost energy and performance during physical activities. Depending on your goals, ...

This summer, the U.S. Department of Agriculture (USDA) is finalizing new national rules for labeling and marketing lab-grown ...

Seafood is the most common way people are exposed to mercury, according to the U.S. Food and Drug Administration.

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary swelling disorder, sending its shares up 33.3% in premarket trading.

Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to ...